Leaps by Bayer has put $50m into xenotransplantation technology developer eGenesis as part of a $100m series B round that followed a $38m series A backed by Heritage Provider Network.

AiCure has picked up series C capital from investors such as Singtel Innov8 and Asahi Kasei to bolster its commercial, engineering and R&D efforts.

Axis Capital and CNO Financial Group invested in health insurance portal Healthcare.com’s second funding round, proceeds of which will support product development and other growth objectives.

Mayo Clinic Ventures pumped in a share of the proceeds for Cadence Neuroscience, which is working on biomarker-powered neuromodulation therapies for drug resistant-focal epilepsy.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The Inserm spinout secured a $7.8m series B extension and boosted its portfolio with the acquisition of AVCare, a Satt Ouest Valorisation-allied business.

AstraZeneca has partnered CICC to launch a fund that will invest in Chinese startups exploiting technologies such as artificial intelligence to improve healthcare.

Indian Angel Network has achieved a final close of $53m for its inaugural fund thanks to limited partners including Hyundai, Max Group, India Infoline and Yes Bank.

Astellas has re-invested in Coda Biotherapeutics, which is working on therapies for conditions such as focal epilepsy and chronic neuropathic pain.

Emerging Technology Partners has returned for a $30m round for HLI, which last closed a $220m series B three years ago backed by Illumina, Celgene and GE.